Two Sigma Investments’s Myriad Genetics MYGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.89M Buy
544,454
+529,954
+3,655% +$2.81M 0.01% 1541
2025
Q1
$129K Buy
+14,500
New +$129K ﹤0.01% 2868
2024
Q2
Sell
-20,400
Closed -$435K 3133
2024
Q1
$435K Sell
20,400
-16,800
-45% -$358K ﹤0.01% 2333
2023
Q4
$712K Buy
37,200
+2,800
+8% +$53.6K ﹤0.01% 2195
2023
Q3
$552K Buy
34,400
+4,200
+14% +$67.4K ﹤0.01% 2162
2023
Q2
$700K Buy
30,200
+13,100
+77% +$304K ﹤0.01% 2093
2023
Q1
$397K Sell
17,100
-9,640
-36% -$224K ﹤0.01% 2234
2022
Q4
$388K Buy
+26,740
New +$388K ﹤0.01% 2072
2021
Q3
Sell
-86,256
Closed -$2.64M 2815
2021
Q2
$2.64M Sell
86,256
-271,667
-76% -$8.31M 0.01% 1203
2021
Q1
$10.9M Sell
357,923
-249,170
-41% -$7.59M 0.03% 557
2020
Q4
$12M Sell
607,093
-368,327
-38% -$7.28M 0.03% 462
2020
Q3
$12.7M Buy
975,420
+222,831
+30% +$2.91M 0.05% 369
2020
Q2
$8.53M Buy
752,589
+633,786
+533% +$7.19M 0.04% 379
2020
Q1
$1.7M Buy
118,803
+104,917
+756% +$1.5M 0.01% 743
2019
Q4
$378K Buy
+13,886
New +$378K ﹤0.01% 1794
2017
Q3
Sell
-249,721
Closed -$6.45M 2142
2017
Q2
$6.45M Sell
249,721
-238,414
-49% -$6.16M 0.02% 619
2017
Q1
$9.37M Sell
488,135
-770,850
-61% -$14.8M 0.03% 563
2016
Q4
$21M Buy
1,258,985
+664,319
+112% +$11.1M 0.08% 264
2016
Q3
$12.2M Sell
594,666
-136,129
-19% -$2.8M 0.04% 399
2016
Q2
$22.4M Buy
730,795
+400,509
+121% +$12.3M 0.1% 243
2016
Q1
$12.4M Sell
330,286
-131,707
-29% -$4.93M 0.06% 351
2015
Q4
$19.9M Buy
461,993
+190,733
+70% +$8.23M 0.1% 241
2015
Q3
$10.2M Buy
271,260
+240,074
+770% +$9M 0.05% 353
2015
Q2
$1.06M Buy
+31,186
New +$1.06M ﹤0.01% 1380
2014
Q3
Sell
-114,088
Closed -$4.44M 1947
2014
Q2
$4.44M Sell
114,088
-477,119
-81% -$18.6M 0.02% 741
2014
Q1
$20.2M Buy
591,207
+519,856
+729% +$17.8M 0.11% 261
2013
Q4
$1.5M Sell
71,351
-205,779
-74% -$4.32M 0.01% 1134
2013
Q3
$6.51M Buy
+277,130
New +$6.51M 0.04% 456